Evaluation of CA125 and HE4 Assays to Estimate the Risk of Ovarian Cancer in Patients Presenting to a General Surgeon or Obstetrician/Gynecologist With an Adnexal Mass
Observational
Observational Model: Case-Only, Time Perspective: Prospective
1. A statistically higher number of cancer patients are correctly assigned by the combination of Initial Cancer Risk assessment and positive ROMA test result than by Initial Cancer Risk assessment alone
Blood draw within 30 days of surgery
No
Richard Moore, MD, FACOG, FACS
Principal Investigator
Women & Infants Hospital Rhode Island
United States: Institutional Review Board
FDI-15
NCT00987649
October 2009
September 2010
Name | Location |
---|---|
Geisinger Medical Center | Danville, Pennsylvania 17822-0001 |
University of Oklahoma Health Sciences Center | Oklahoma City, Oklahoma 73104 |
Weill Medical College of Cornell University | New York, New York 10021 |
New Hanover Regional Medical Center | Wilmington, North Carolina 28402-9025 |
Woman's Hospital | Baton Rouge, Louisiana 70815 |
Chattanooga GYN-Oncology | Chattanooga, Tennessee 37403 |
OB/GYN Specialists of the Palm Beaches | West Palm Beach, Florida 33401 |
Scripps Clinic Carmel Valley | San Diego, California 92130 |
Women's Clinic of Northern Colorado | Fort Collins, Colorado 80524 |
University of South Florida Medical Center | Tampa, Florida 33606 |
Women & Infants Hospital Rhode Island | Providence, Rhode Island 02905 |
Jackson Clinic | Jackson, Tennessee 38305 |
Adams Patterson Gynecology & Obstetrics | Memphis, Tennessee 38120 |